JPWO2025169865A5 - - Google Patents

Info

Publication number
JPWO2025169865A5
JPWO2025169865A5 JP2025568955A JP2025568955A JPWO2025169865A5 JP WO2025169865 A5 JPWO2025169865 A5 JP WO2025169865A5 JP 2025568955 A JP2025568955 A JP 2025568955A JP 2025568955 A JP2025568955 A JP 2025568955A JP WO2025169865 A5 JPWO2025169865 A5 JP WO2025169865A5
Authority
JP
Japan
Prior art keywords
galnac
pharmaceutical composition
preventing
rheumatoid arthritis
osteoarthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025568955A
Other languages
English (en)
Japanese (ja)
Other versions
JP7840505B2 (ja
JPWO2025169865A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2025/003340 external-priority patent/WO2025169865A1/ja
Publication of JPWO2025169865A1 publication Critical patent/JPWO2025169865A1/ja
Publication of JPWO2025169865A5 publication Critical patent/JPWO2025169865A5/ja
Application granted granted Critical
Publication of JP7840505B2 publication Critical patent/JP7840505B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025568955A 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物 Active JP7840505B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024015445 2024-02-05
JP2024015445 2024-02-05
PCT/JP2025/003340 WO2025169865A1 (ja) 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2025169865A1 JPWO2025169865A1 (https=) 2025-08-14
JPWO2025169865A5 true JPWO2025169865A5 (https=) 2026-01-28
JP7840505B2 JP7840505B2 (ja) 2026-04-03

Family

ID=96699915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025568955A Active JP7840505B2 (ja) 2024-02-05 2025-02-03 変形性関節症及び／又は関節リウマチの予防及び／又は治療用医薬組成物

Country Status (2)

Country Link
JP (1) JP7840505B2 (https=)
WO (1) WO2025169865A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008078588A1 (ja) * 2006-12-25 2010-04-22 国立大学法人 東京医科歯科大学 関節軟骨の変性を治療又は予防するための医薬及び方法
US8530420B2 (en) * 2008-12-16 2013-09-10 Kaohsiung Medical University Treatment of arthritis with parathyroid hormone
JP2021084867A (ja) * 2019-11-27 2021-06-03 学校法人慶應義塾 変形性関節症の予防薬及び治療薬

Similar Documents

Publication Publication Date Title
JP2024109585A5 (https=)
Soll et al. Medical treatment of peptic ulcer disease: practice guidelines
EA202191361A1 (ru) Способы лечения муковисцидоза
DE60042598D1 (de) Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist.
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
JP2024028658A5 (https=)
KR940006578A (ko) 2-(3,4-디메톡신나모일) 아미노벤조산
EP4424328A3 (en) Treatment of hidradenitis suppurativa using jak inhibitors
JP2019194191A5 (https=)
IL314009B2 (en) Parp1 inhibitors and their uses
IL316433A (en) Bicyclic heterocyclic amide inhibitors of NA v1.8 for the treatment of pain
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
EP3541943A4 (en) MICRO-ORGANISM FOR ADMINISTERING A MEDICINAL PRODUCT FOR THE TREATMENT OF A GASTROINTESTINAL DISEASE, WHICH EXPRESSES AND SECRETS P8 PROTEIN, AND PHARMACEUTICAL COMPOSITION CONSISTING OF THIS MICRO-ORGANISM FOR THE PREVENTION OR TREATMENT OF A GASTROINTESTINAL DISEASE
JPWO2025169865A5 (https=)
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
EP4640226A4 (en) USE OF CHRISTENSENELLA SP. OR A COMPOSITION CONTAINING IT IN THE PREVENTION OR TREATMENT OF TUMORS, AND MEDICINE CONTAINING IT
EP3763375A4 (en) CELL PREPARATION FOR TREATMENT AND / OR PREVENTION OF ISCHEMIC DISEASE AND METHOD OF SCREENING A CELL PREPARATION
RU2001124802A (ru) Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных средств, применяемых для лечения или предупреждения расстройств настроения, расстройств адаптации или смешанных тревожно-депрессивных расстройств
JP2005507888A5 (https=)
EE200100553A (et) Saredutandi ja selle farmatseutiliselt vastuvõetavate soolade kasutamine meeleoluhäirete, kohanemishäirete või segatüüpi ärev-depressiivsete häirete raviks või vältimiseks kasulike ravimite valmistamiseks
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
WO2020060779A3 (en) Methods and compositions for treating laminopathies affecting skeletal or cardiac muscle
JPWO2023191035A5 (https=)
JP2020530472A5 (https=)
NO20053290D0 (no) Fremgangsmate og anlegg for termisk behandling av kornet torrstoff.